Essential Strategies For Gene Therapy - From Assay Development To CDx Commercialization

Innovators developing gene therapies face a multitude of challenges, from the lab to the FDA. Yet a number of successful strategies are emerging that are mitigating the risks, reducing costs and smoothing out the road to approval. Listen to a panel of gene therapy experts with unique perspectives and real-world experiences share successful approaches in gene therapy development, CDx development and commercialization.

Attendees Will Hear:

• Factors in the NAb vs. TAb assay choice, including respective assay development challenges and agency outlooks
• How to make the most of early engagement and collaboration with regulatory agencies
• How to plan and prepare for CDx development from the beginning of assay development
• New approaches for CDx regulatory approval and commercialization